[18] [19] [20] It is a peptide similar to the hormone glucagon-like peptide-1 (GLP-1), modified with a side chain
Currently, semaglutide is only approved for weight loss under the brand name Wegovy
Includes dosages for Diabetes Type 2, Weight Loss and Cardiovascular Risk Reduction; plus renal, liver and dialysis adjustments
I’ve only been on semaglutide injections for about 3 months
Oral route (Tablet) Warning: Risk of Thyroid C-Cell TumorsIn rodents, semaglutide causes thyroid C-cell tumors
Your doctor may order certain tests to check your body's response to
Those who experience chest pain, troubled breathing, difficulty swallowing, increased heart rate, or unusual tiredness In rodents, semaglutide causes dose-dependent and treatment-duration-dependent thyroid C-cell tumors at clinically relevant exposures
If you notice a lump in your neck, difficulty swallowing, shortness of breath, or hoarseness that doesn't go away, let your healthcare provider know right
It is unknown whether semaglutide causes thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in humans as the human relevance of semaglutide-induced rodent thyroid C-cell tumors has not been
It can cause some side effects, such as nausea, vomiting, diarrhea, and stomach pain
The glucagon-like peptide-1 receptor agonist (GLP-1RA) semaglutide is the most recently approved agent of this drug class, and the only GLP-1RA currently available as both subcutaneous and oral formulation
These criteria vary by brand, as each is formulated for a different use